Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2015

SVELTE MEDICAL SYSTEMS INC

Offering
$42.7M
Sold
$38.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW PROVIDENCE, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Phillip D. Torrence · New Providence, NJExecSomu A. Subramaniam · New Providence, NJDirectorRobert A. Croce · New Providence, NJDirectorRobert A. Flanagan · New Providence, NJDirectorMark A. Kielek · New Providence, NJExecJack A. Darby · New Providence, NJExec · DirectorRichard A. Dakers · New Providence, NJDirectorRichard T. Spencer · New Providence, NJExecBilal Sassa · Port Louis, O4DirectorBrett A. Gookin · San Francisco, CAExecMichael A. Weisman · New York, NYDirectorDaniel Klein · Chicago, ILDirectorRichard T. Spencer · New Providence, NJExecJack A. Darby · New Providence, NJExec · DirectorSomu A. Subramaniam · New Providence, NJDirectorMark A. Kielek · New Providence, NJExecRobert A. Croce · New Providence, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗